| Financial Year |
March 31 2023 |
| Monetary Funds |
208,862,301.97 |
| Held-for-trading Financial Assets |
34,309,693.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
237,189,158.62 |
| Advances to Suppliers |
87,383,980.18 |
| Other Receivables |
172,712,946.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
346,845,470.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,208,500.07 |
| Total Current Assets |
1,123,715,393.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
256,735,406.63 |
| Investment Properties |
2,988,786.13 |
| Fixed Assetes |
823,328,390.61 |
| Under-construction Projects |
100,576,598.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
274,231,592.11 |
| R&D expenses |
432,000.00 |
| Goodwill |
273,983,187.99 |
| Long-Term Deferred and Prepaid Expenses |
18,974,405.58 |
| Deferred Income Tax Assets |
9,102,559.25 |
| Other Non-Current Assets |
75,192,759.43 |
| Sub-Total of Non-Current Assets |
1,859,416,466.64 |
| Total Assets |
2,983,131,860.61 |
| Short-Term Loans |
135,521,222.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
119,895,082.62 |
| Accounts Payable |
128,202,383.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,726,876.25 |
| Taxes Payable |
41,801,932.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
459,412,814.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,525,328.61 |
| Other Current Liabilities |
2,591,825.18 |
| Sub-Total of Current Liabilities |
952,615,299.33 |
| Long-term Loans |
302,850,926.27 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
44,905,774.54 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
33,043,034.66 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
439,866,493.73 |
| Total Liabilities |
1,392,481,793.06 |
| Paid-In Capital(Or Share Stock) |
440,451,120.00 |
| Capital Surplus |
171,556,743.56 |
| Surplus Reserve |
112,006,471.81 |
| LESS:Treasury Stock |
32,961,150.00 |
| Undistributed Profits |
768,437,508.34 |
| Minority Stockholder's Interest |
131,234,243.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,459,415,824.17 |
| Owner's Equity（Stockholder's Equity） |
1,590,650,067.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,983,131,860.61 |
